Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease

Abciximab readministration: results of the ReoPro Readministration Registry.

Circulation·2001

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.

American heart journal·2001

Renal artery angioplasty and stent placement: predictors of a favorable outcome.

American heart journal·2000

Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators.

Catheterization and cardiovascular diagnosis·1998

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Circulation·1998

Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

Journal of the American College of Cardiology·1998

Antithrombotic therapy and device healing after left atrial appendage occlusion with WATCHMAN FLX Pro: a single-center real-world cohort study.

The Journal of invasive cardiology·2026

Totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic vascular grafts: a single-center case series.

The Journal of invasive cardiology·2026

Phenotype-specific mitral regurgitation trajectories following transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026

Success rate and proposed mechanism of balloon rupture in hemostasis with MYNX CONTROL.

The Journal of invasive cardiology·2026

Large language models in interventional cardiology: current evidence and future directions.

The Journal of invasive cardiology·2026

Access to atrial flow regulators for implantation in critically ill children via the US Food and Drug Administration's emergency use pathway.

The Journal of invasive cardiology·2026

Extremely Deep Myocardial Bridge With Fixed-Like Coronary Stenosis.

JACC. Case reports·2026

Prognostic Impact of CCTA According to Standard Cardiovascular Modifiable Risk Factors.

JACC. Advances·2026

Dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome and non-valvular atrial fibrillation undergoing percutaneous coronary intervention (ADONIS-PCI): protocol for a randomized controlled pilot trial.

Cardiology journal·2026

Left atrial appendage clip causing left main coronary artery occlusion and mortality despite removal.

Interdisciplinary cardiovascular and thoracic surgery·2026

Atenolol or Bisoprolol after Myocardial Infarction without Recorded Heart Failure.

NEJM evidence·2026

Prognostic Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve From a Large Nationwide Cohort.

Circulation·2026

Related Experiment Videos

Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease

Related Concept Videos

Abciximab readministration: results of the ReoPro Readministration Registry.

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.

Renal artery angioplasty and stent placement: predictors of a favorable outcome.

Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators.

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

Antithrombotic therapy and device healing after left atrial appendage occlusion with WATCHMAN FLX Pro: a single-center real-world cohort study.

Totally percutaneous transfemoral transcatheter aortic valve replacement via synthetic vascular grafts: a single-center case series.

Phenotype-specific mitral regurgitation trajectories following transcatheter aortic valve replacement in low-flow aortic stenosis.

Success rate and proposed mechanism of balloon rupture in hemostasis with MYNX CONTROL.

Large language models in interventional cardiology: current evidence and future directions.

Access to atrial flow regulators for implantation in critically ill children via the US Food and Drug Administration's emergency use pathway.

Extremely Deep Myocardial Bridge With Fixed-Like Coronary Stenosis.

Prognostic Impact of CCTA According to Standard Cardiovascular Modifiable Risk Factors.

Dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome and non-valvular atrial fibrillation undergoing percutaneous coronary intervention (ADONIS-PCI): protocol for a randomized controlled pilot trial.

Left atrial appendage clip causing left main coronary artery occlusion and mortality despite removal.

Atenolol or Bisoprolol after Myocardial Infarction without Recorded Heart Failure.

Prognostic Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve From a Large Nationwide Cohort.

Related Experiment Videos

Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease

Related Concept Videos

Related Articles